genetically modified plasmodium parasites protective experimental malaria vaccine 
malaria mosquito-borne disease transmitted inoculation plasmodium parasite sporozoite stage sporozoites invade hepatocytes transform liver stages subsequent liver-stage development ultimately results release pathogenic merozoites liver stages parasite prime target malaria vaccines can completely eliminated sterilizing immune responses thereby preventing malarial infection using expression profiling previously identified genes expressed pre-erythrocytic stages parasite show reverse genetics one identified gene uis3 upregulated infective sporozoites gene essential early liver-stage development uis3-deficient sporozoites infect hepatocytes unable establish blood-stage infections vivo thus lead disease immunization uis3-deficient sporozoites confers complete protection infectious sporozoite challenge rodent malaria model protection sustained stage specific findings demonstrate safe effective genetically attenuated whole-organism malaria vaccine possible 
